The legacy of the blue pill offers a complex case study for stakeholders eyeing pharma. While early sales were remarkable, recent patent lapse and the rise of generic versions have severely affected revenues. In https://dianehbas536412.ambien-blog.com/47885983/viagra-and-big-pharma-a-risky-stake